9 results about "Cardiogenic shock" patented technology

1. Name of the product in this design: Percutaneous ventricular assist device. 2. Purpose of this design: for use in medical and health care, for emergency support in cases of acute myocardial infarction, cardiogenic shock, high-risk PCI, etc. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: 3D view 1.

A subject can be treated for cardiogenic shock and / or sepsis, or their symptoms using platelet-derived extracellular vesicles (PEVs) or mitlets that include PEVS. The PEVs include mitochondria. The PEVs can be collected by obtaining blood from one or more donors, adding an anticoagulant and a buffer to the blood to form a mix, separating the mix into supernatant and platelet rich plasma (PRP), collecting the PRP and stimulating the collected PRP, thereby expelling extracellular vesicles from platelets in the PRP, and collecting the extracellular vesicles as the PEVs. PEVs can also be isolated from source cells grown in a bioreactor and suspended in a buffer to preserve the PEVs.

The invention discloses compounds of Formula (I), wherein the compounds are used as anti-inflammatory agents, for treatment or prevention of a number of diseases or conditions such as atherosclerosis, auto-immune diseases, psoriasis, multiple sclerosis, transplant rejection, asthma, bacterial infection, rhinovirus infection, brain ischemia, ischemia-reperfusion injury, limb ischemia, acute kidney injury, diabetic nephropathy, sepsis, acute respiratory distress syndrome (ARDS), cancer, osteoarthritis, sepsis-induced kidney injury, liver disease, and septic and cardiogenic shock.

1. The name of the design product: main trolley. 2. The use of the design product: for clinical first aid of myocardial infarction, cardiogenic shock and other serious coronary heart disease. 3. The design points of the design product: in shape. 4. The picture or photo that can best show the design points: perspective drawing.

A method (100) for training a hemodynamic instability cause classification model to classify a patient's determined likelihood of future hemodynamic instability as caused by one or more of cardiogenic shock, septic shock, and hypovolemic shock, the method comprising: (i) receiving (120) a preliminary cause classification model training dataset; (ii) analyzing (130) the received dataset to classify each patient as likely to be hemodynamically unstable; (iii) analyzing (140) the received patient information by an outlier detection model to determine whether that patient's hemodynamic instability is likely to be cardiogenic shock, septic shock, hypovolemic shock, or an outlier; (iv) generating (150) a final cause classification model training dataset by removing each of the patients determined as being an outlier; and (v) training (160) the hemodynamic instability cause classification model to classify a cause of the patient's determined likelihood of future hemodynamic instability.

1. The name of the design product: IABP host trolley. 2. The use of the design product: for clinical first aid of severe coronary heart disease such as cardiac insufficiency, myocardial infarction, cardiogenic shock, etc. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: perspective view 2. 5. The bottom view of the design product is not easy to see or not visible during use, and the bottom view is omitted.

The invention discloses compounds of Formula (I), wherein the compounds are used as anti-inflammatory agents, for treatment or prevention of a number of diseases or conditions such as atherosclerosis, auto-immune diseases, psoriasis, multiple sclerosis, transplant rejection, asthma, bacterial infection, rhinovirus infection, brain ischemia, ischemia-reperfusion injury, limb ischemia, acute kidney injury, diabetic nephropathy, sepsis, acute respiratory distress syndrome (ARDS), cancer, osteoarthritis, sepsis-induced kidney injury, liver disease, and septic and cardiogenic shock.

Systems and methods are provided herein for treating a patient in cardiogenic shock. An intravascular heart pump system is inserted into vasculature of the patient. The heart pump system has a cannula, pump outlet, pump inlet, and rotor. The heart pump system is positioned within the patient such that the cannula extends across the patient's aortic valve, the pump inlet is located within the patient's left ventricle, and the pump outlet is located within the patient's aorta. Data related to time-varying parameters of the heart pump system is acquired from the heart pump system. A plurality of features are extracted from the data. A probability of survival of the patient is determined based on the plurality of features and using a prediction model. The heart pump system is operated to treat the patient.